Veracyte: Fourth Quarter Financial Overview

Veracyte Announces Fourth-Quarter Financial Results

Veracyte Inc., headquartered in South San Francisco, California, revealed a net profit of $41.1 million for the fourth quarter.

The company’s earnings translated to 51 cents per share, or 53 cents per share when excluding certain one-time items.

These figures surpassed analyst expectations, as the consensus from four analysts polled by Zacks Investment Research had anticipated earnings of 41 cents per share.

During the quarter, Veracyte, a leader in molecular diagnostics, generated $140.6 million in revenue.

For the entire fiscal year, Veracyte reported a total profit of $66.4 million, or 82 cents per share, with annual revenue reaching $517.1 million.

Looking ahead, the company projects its revenue for the upcoming year to fall between $570 million and $582 million.

This article was produced by Automated Insights using data provided by Zacks Investment Research.